Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor
- PMID: 1382313
- DOI: 10.1126/science.1382313
Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor
Abstract
Coronary collateral vessels reduce damage to ischemic myocardium after coronary obstruction. Factors that stimulate collateral formation are expected to have ameliorating effects on myocardial infarction. In a canine experimental myocardial infarct model, intracoronary injection of basic fibroblast growth factor (bFGF) improved cardiac systolic function and reduced infarct size. Treatment with bFGF increased the number of arterioles and capillaries in the infarct. Thus, the angiogenic action of bFGF might lead to a reduction in infarct size. The application of bFGF might bring about a therapeutic modality for the salvage of infarcted myocardium.
Similar articles
-
Basic fibroblast growth factor increased regional myocardial blood flow and limited infarct size of acutely infarcted myocardium in dogs.Angiology. 1998 May;49(5):381-90. doi: 10.1177/000331979804900507. Angiology. 1998. PMID: 9591530
-
Reduction in myocardial infarct size by basic fibroblast growth factor following coronary occlusion in a canine model.Int J Cardiol. 1999 Apr 10;68 Suppl 1:S85-91. doi: 10.1016/s0167-5273(98)00296-4. Int J Cardiol. 1999. PMID: 10328616
-
Intracoronary injection of basic fibroblast growth factor enhances angiogenesis in infarcted swine myocardium.J Am Coll Cardiol. 1993 Dec;22(7):2001-6. doi: 10.1016/0735-1097(93)90790-8. J Am Coll Cardiol. 1993. PMID: 7504006
-
Angiogenic processes in the pathogenesis of human coronary atherosclerosis.Curr Top Pathol. 1993;87:47-58. doi: 10.1007/978-3-642-76849-1_2. Curr Top Pathol. 1993. PMID: 7510224 Review. No abstract available.
-
The role of insulin-like and basic fibroblast growth factors on ischemic and infarcted myocardium: a mini review.Int J Cardiol. 1997 Mar;59(1):1-5. doi: 10.1016/s0167-5273(96)02902-6. Int J Cardiol. 1997. PMID: 9080019 Review.
Cited by
-
Therapeutic myocardial angiogenesis: past, present and future.Mol Cell Biochem. 2004 Sep;264(1-2):75-83. doi: 10.1023/b:mcbi.0000044376.78158.51. Mol Cell Biochem. 2004. PMID: 15544037 Review.
-
Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model.J Clin Invest. 1994 Feb;93(2):662-70. doi: 10.1172/JCI117018. J Clin Invest. 1994. PMID: 7509344 Free PMC article.
-
Basic fibroblast growth factor is cardioprotective in ischemia-reperfusion injury.Mol Cell Biochem. 1995 Feb 23;143(2):129-35. doi: 10.1007/BF01816946. Mol Cell Biochem. 1995. PMID: 7596347
-
A new 34-kilodalton isoform of human fibroblast growth factor 2 is cap dependently synthesized by using a non-AUG start codon and behaves as a survival factor.Mol Cell Biol. 1999 Jan;19(1):505-14. doi: 10.1128/MCB.19.1.505. Mol Cell Biol. 1999. PMID: 9858574 Free PMC article.
-
New collateral flow increasing early after coronary occlusion prevented myocardial necrosis in dogs.Heart Vessels. 1995;10(4):171-7. doi: 10.1007/BF01744982. Heart Vessels. 1995. PMID: 8530320
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical